A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

Lucia Masarova, Srdan Verstovsek, Juliana E. Hidalgo-Lopez, Naveen Pemmaraju, Prithviraj Bose, Zeev Estrov, Elias J. Jabbour, Farhad Ravandi-Kashani, Koichi Takahashi, Jorge E. Cortes, Jing Ning, Maro Ohanian, Yesid Alvarado, Lingsha Zhou, Sherry Pierce, Romany Gergis, Keyur P. Patel, Rajyalakshmi Luthra, Tapan M. Kadia, Courtney D. DiNardoGautam Borthakur, Kapil Bhalla, Guillermo Garcia-Manero, Carlos E. Bueso-Ramos, Hagop M. Kantarjian, Naval Daver

Research output: Contribution to journalArticle

15 Scopus citations

Fingerprint Dive into the research topics of 'A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences